Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Athersys Stock Performance Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The stock […]

Leave a Reply

Your email address will not be published.

Previous post Lipocine (NASDAQ:LPCN) Earns Hold Rating from Analysts at StockNews.com
Next post Nutanix (NASDAQ:NTNX) Rating Lowered to Buy at StockNews.com